Ifp Advisors, Inc Grifols Sa Transaction History

Ifp Advisors, Inc

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 08, 2022	BUY	$5.95 - $14.3 $333 - $800	56 New	56 $1,000
Q3 2021 Oct 06, 2021	SELL	$14.07 - $17.3 $0 - $0	0 Closed	0 $0
Q2 2021 Jul 13, 2021	BUY	$16.62 - $18.94 $0 - $0	0 New	0 $0
Q1 2021 Apr 30, 2021	BUY	$15.15 - $19.78 $0 - $0	0 New	0 $0
Q4 2020 Jan 25, 2021	BUY	$16.86 - $19.67 $0 - $0	0 New	0 $0
Q3 2020 Oct 29, 2020	BUY	$15.4 - $20.16 $0 - $0	0 New	0 $0
Q2 2020 Aug 05, 2020	BUY	$18.24 - $21.45 $0 - $0	0 New	0 $0
Q1 2020 May 12, 2020	BUY	$16.28 - $25.63 $0 - $0	0 New	0 $0
Q4 2019 Jan 17, 2020	BUY	$19.57 - $23.52 $0 - $0	0 New	0 $0
Q3 2019 Nov 07, 2019	BUY	$19.85 - $22.76 $0 - $0	0 New	0 $0
Q1 2019 May 15, 2019	SELL	$18.01 - $20.11 $2,125 - $2,372	-118 Closed	0 $0
Q4 2018 Jan 23, 2019	SELL	$17.44 - $21.53 $4,708 - $5,813	-270 Reduced 69.59%	118 $2,000
Q2 2018 Aug 07, 2018	BUY	$20.16 - $24.68 $6,491 - $7,946	322 Added 487.88%	388 $0
Q4 2016 Jun 03, 2019	SELL	N/A	-52 Reduced 44.07%	66 $1,000
Q2 2016 Jun 03, 2019	BUY	N/A	118	118 $2,000

164

140M

288K

389K

Ticker GRFS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 678,910,976
Market Cap $5.33B
Description
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.